Combination of diabetes and heart disease substantially reduces life expectancy
Life expectancy for people with a history of both cardiovascular disease and diabetes is substantially lower than for people with just one condition or no disease, a new study harnessing the power of ‘big data’ has concluded.
Our results highlight the importance of preventing heart disease and stroke amongst patients with diabetes, and likewise averting diabetes amongst heart disease patients
Researchers at the University of Cambridge analysed more than 135,000 deaths which occurred during prolonged follow-up of almost 1.2 million participants in population cohorts. They used this to provide estimates of reductions in life expectancy associated with a history of different combinations of diabetes, stroke, and/or myocardial infarction heart attack – so-called cardiometabolic diseases. Their results are published today in JAMA (The Journal of the American Medical Association).
The team analysed data from the Emerging Risk Factors Collaboration (ERFC) from almost 700,000 participants recruited between 1960 and 2007, taken from a total of 91 prospective cohorts that have recorded mortality during prolonged follow-up. They compared the results with those from the UK Biobank, a prospective cohort of just under 500,000 participants recruited between 2006 and 2010.
Previous studies have estimated that around 10 million adults in the United States and the European Union are living with more than one cardiometabolic illness. In this new study, the researchers found that around one person in a hundred from the cohorts they analysed had two or more conditions.
“We showed that h Continue reading